CDC: mRNA vaccines just 53.1% effective against Delta infection among nursing home residents

AY.3, B.1.617.2, Coronavirus, Delta, Delta-AY.3, Hospitalization, Infection, Moderna, Pfizer/Biontech, Science, Transmission, USA, Vaccine, Vaccine Breakthrough, Vaccine Waning, Variants

“Two doses of mRNA vaccines were 74.7% effective against infection among nursing home residents early in the vaccination program. During June–July 2021, when B.1.617.2 (Delta) variant circulation predominated, effectiveness declined significantly to 53.1%”

This study could not differentiate the independent impact of the Delta variant from other factors, such as potential waning of vaccine-induced immunity. Further research on the possible impact of both factors on VE among nursing home residents is warranted. Because nursing home residents might remain at some risk for SARS-CoV-2 infection despite vaccination, multipronged COVID-19 prevention strategies, including infection control, testing, and vaccination of nursing home staff members, residents, and visitors are critical.

CDC report:   Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021


Belgium: 7 fully vaccinated care home residents die after contracting B.1.621 Mu variant first found in Colombia


** This post was originally published on August 21, 2021 **